ACM
TMO icon

Azimuth Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Azimuth Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.58M Sell
2,670
-10
-0.4% -$5.74K 0.07% 205
2021
Q4 		$1.79M Sell
2,680
-35
-1% -$21.9K 0.07% 204
2021
Q3 		$1.55M Sell
2,715
-3
-0.1% -$1.65K 0.07% 204
2021
Q2 		$1.37M Buy
2,718
+8
+0.3% +$3.77K 0.06% 218
2021
Q1 		$1.24M Buy
2,710
+475
+21% +$227K 0.06% 222
2020
Q4 		$1.04M Hold
2,235
– – 0.05% 220
2020
Q3 		$987K Sell
2,235
-267
-11% -$110K 0.06% 204
2020
Q2 		$907K Sell
2,502
-33
-1% -$11.1K 0.06% 206
2020
Q1 		$719K Sell
2,535
-61
-2% -$19.2K 0.05% 214
2019
Q4 		$843K Sell
2,596
-300
-10% -$91K 0.05% 212
2019
Q3 		$844K Sell
2,896
-95
-3% -$27.2K 0.06% 210
2019
Q2 		$878K Sell
2,991
-25
-0.8% -$6.89K 0.06% 209
2019
Q1 		$826K Buy
3,016
+320
+12% +$79.6K 0.06% 216
2018
Q4 		$603K Sell
2,696
-219
-8% -$51.4K 0.05% 223
2018
Q3 		$711K Hold
2,915
– – 0.05% 218
2018
Q2 		$604K Hold
2,915
– – 0.04% 221
2018
Q1 		$602K Sell
2,915
-5
-0.2% -$1.05K 0.04% 221
2017
Q4 		$554K Sell
2,920
-250
-8% -$47.9K 0.04% 227
2017
Q3 		$600K Hold
3,170
– – 0.04% 223
2017
Q2 		$553K Sell
3,170
-40
-1% -$6.72K 0.04% 228
2017
Q1 		$493K Buy
3,210
+25
+0.8% +$3.82K 0.04% 232
2016
Q4 		$449K Buy
3,185
+435
+16% +$64.1K 0.04% 234
2016
Q3 		$437K Hold
2,750
– – 0.04% 232
2016
Q2 		$406K Buy
+2,750
New +$406K 0.04% 236

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Azimuth Capital Management's TMO Position: Q1 2022 in Review

Azimuth Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.37% in Q1 2022, selling an estimated $5.74K and leaving 2,670 shares worth $1.58M. The position accounts for 0.07% of the portfolio, ranked #205.

Azimuth Capital Management first reported a position in TMO in Q2 2016 and has held it in 24 quarters since. The position peaked at $1.79M in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Azimuth Capital Management held 2,670 shares of Thermo Fisher Scientific worth $1.58M as of Q1 2022.
  • Azimuth Capital Management sold 10 Thermo Fisher Scientific shares in Q1 2022, an estimated $5.74K.
  • Thermo Fisher Scientific made up 0.07% of Azimuth Capital Management's portfolio in Q1 2022, its #205 holding.
  • Azimuth Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 24 quarters since.
  • Azimuth Capital Management's Thermo Fisher Scientific position peaked at $1.79M in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.